Get the latest Science News and Discoveries

Adding ipilimumab to pembrolizumab does not improve efficacy in patients with NSCLC

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of NSCLC

NSCLC

Related news:

Sotorasib provides durable clinical benefit for patients with NSCLC and KRAS mutations

« President Biden’s Executive Actions Signal Commitment to Science for the Public Good

"NASA may change MRO orbit to support Mars 2020" »